Literature DB >> 10926917

Understanding and identifying monoclonal gammopathies.

M Attaelmannan1, S S Levinson.   

Abstract

Monoclonal gammopathies reflect conditions in which abnormal amounts of immunoglobulins are produced by a clone that developed from a single pro-B germ cell. The condition may reflect a disease process or be benign. The primary purpose of this review is to emphasize routine clinical laboratory techniques that currently are recommended for use in identifying monoclonal gammopathies from serum and urine. Selection of the preferred technique and correct interpretation often is dependent on an understanding of the immunological basis and clinical sequelae associated with these conditions. For this reason, we first briefly discuss the structure, production, and nature of immunoglobulins, and then describe important features of the associated diseases. Finally, we discuss strengths and weaknesses of the techniques and make reference to current recommendations to facilitate optimal testing. We discuss in detail high-resolution electrophoresis, methods for quantifying immunoglobulins, immunofixation electrophoresis, problems associated with analysis of urine immunoglobulins, and identification of cryoglobulins and immune complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926917

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  19 in total

1.  Reporting of quantitative protein electrophoresis in Australia and New Zealand: a call for standardisation.

Authors:  Zoe Inman; Helen Martin; S A Paul Chubb
Journal:  Clin Biochem Rev       Date:  2009-08

2.  Monoclonal gammopathies in a Moroccan military hospital.

Authors:  Z Ouzzif; K Doghmi; S Bouhsain; A Dami; S El Machtani; S Tellal; N Messaoudi; M Mikdame; A El Maataoui
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

3.  Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern.

Authors:  Bharani Vani; Aggarwal Ritu; Sharma Praveen; Malhotra Pankaj; Ranjana Minz
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-31       Impact factor: 0.900

Review 4.  Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.

Authors:  Mariana Ciocchini; Jorge Arbelbide; Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2017-04-19       Impact factor: 2.370

5.  A Rare Case of Acquired Fanconi's Syndrome With Monoclonal Gammopathy in an Infant.

Authors:  Brian Castillo; Brian N Chang; Amer Wahed; Ashok Tholpady
Journal:  J Clin Lab Anal       Date:  2015-10-29       Impact factor: 2.352

Review 6.  Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma.

Authors:  Aroonima Misra; Jyoti Mishra; Jagan Chandramohan; Atul Sharma; Vinod Raina; Rajive Kumar; Sushant Soni; Anita Chopra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-13       Impact factor: 0.900

7.  A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies.

Authors:  Eldho Kuriakose; Sumithra Narayanan Unni Cheppayil; Subhakumari Kuzhikandathil Narayanan; Anu Vasudevan
Journal:  Indian J Clin Biochem       Date:  2017-11-29

Review 8.  Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates.

Authors:  Jann P Foster; Rakesh Seth; Michael J Cole
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04

9.  Case Report: Monoclonal Gammopathy of Undetermined Significance is Associated with Loa loa Infection.

Authors:  Derek B Laskar; Michael Rose; Raavi Gupta; Herbert B Tanowitz; M A Haseeb
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

10.  Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.

Authors:  Francisca Barceló; Joan J Cerdà; Antonio Gutiérrez; Teresa Jimenez-Marco; M Antonia Durán; Andrés Novo; Teresa Ros; Antonia Sampol; José Portugal
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.